Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 242

    1.

    Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.

    Inzucchi SE, Masoudi FA, Wang Y, Kosiborod M, Foody JM, Setaro JF, Havranek EP, Krumholz HM.

    Diabetes Care. 2005 Jul;28(7):1680-9.PMID: 15983320 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.

    Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM.

    Circulation. 2005 Feb 8;111(5):583-90.PMID: 15699279 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

    Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA.

    JAMA. 2007 Dec 12;298(22):2634-43.PMID: 18073359 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.

    Aguilar D, Bozkurt B, Pritchett A, Petersen NJ, Deswal A.

    J Am Coll Cardiol. 2007 Jul 3;50(1):32-6. Epub 2007 Jun 18.PMID: 17601542 [PubMed - indexed for MEDLINE]Related articles

    5.

    Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.

    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.

    Clin Ther. 2004 Sep;26(9):1400-10.PMID: 15531002 [PubMed - indexed for MEDLINE]Related articles

    6.

    Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project.

    Chen J, Marciniak TA, Radford MJ, Wang Y, Krumholz HM.

    J Am Coll Cardiol. 1999 Nov 1;34(5):1388-94.PMID: 10551683 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metformin and thiazolidinedione use in Medicare patients with heart failure.

    Masoudi FA, Wang Y, Inzucchi SE, Setaro JF, Havranek EP, Foody JM, Krumholz HM.

    JAMA. 2003 Jul 2;290(1):81-5.PMID: 12837715 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.

    Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD.

    Pharmacoepidemiol Drug Saf. 2007 May;16(5):504-12.PMID: 17245800 [PubMed - indexed for MEDLINE]Related articles

    9.

    National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

    Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA.

    JAMA. 1998 Aug 19;280(7):623-9. Erratum in: JAMA 1999 Jan 6;281(1):37. PMID: 9718054 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

    Habib ZA, Tzogias L, Havstad SL, Wells K, Divine G, Lanfear DE, Tang J, Krajenta R, Pladevall M, Williams LK.

    Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):437-47.PMID: 19235778 [PubMed - indexed for MEDLINE]Related articles

    11.

    Coronary heart disease outcomes in patients receiving antidiabetic agents.

    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.

    Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):711-25.PMID: 17551989 [PubMed - indexed for MEDLINE]Related articles

    12.

    Thiazolidinediones in type 2 diabetes: a cardiology perspective.

    Khanderia U, Pop-Busui R, Eagle KA.

    Ann Pharmacother. 2008 Oct;42(10):1466-74. Epub 2008 Sep 2. Review.PMID: 18698014 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rosiglitazone and myocardial infarction in patients previously prescribed metformin.

    Dormuth CR, Maclure M, Carney G, Schneeweiss S, Bassett K, Wright JM.

    PLoS One. 2009 Jun 27;4(6):e6080.PMID: 19562036 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.

    Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS.

    Diabetes Care. 2003 Nov;26(11):2983-9.PMID: 14578227 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.

    Fisman EZ, Tenenbaum A, Boyko V, Benderly M, Adler Y, Friedensohn A, Kohanovski M, Rotzak R, Schneider H, Behar S, Motro M.

    Clin Cardiol. 2001 Feb;24(2):151-8.PMID: 11460818 [PubMed - indexed for MEDLINE]Related articles

    16.

    Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.

    Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M.

    Cardiology. 1999;91(3):195-202.PMID: 10516414 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pioglitazone initiation and subsequent hospitalization for congestive heart failure.

    Karter AJ, Ahmed AT, Liu J, Moffet HH, Parker MM.

    Diabet Med. 2005 Aug;22(8):986-93.PMID: 16026362 [PubMed - indexed for MEDLINE]Related articles

    18.

    Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.

    Hsiao FY, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW.

    Drug Saf. 2009;32(8):675-90. doi: 10.2165/00002018-200932080-00006.PMID: 19591532 [PubMed - indexed for MEDLINE]Related articles

    19.

    Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

    Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

    J Manag Care Pharm. 2006 Mar;12(2):121-9.PMID: 16515370 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data